Business Description
Bio Plus Co Ltd
ISIN : KR7099430001
Compare
Compare
Traded in other countries / regions
099430.Korea IPO Date
2021-09-27Description
Bio Plus Co Ltd is engaged in the development of innovative biomedical and medical devices products through research on bio-material applications platform technology.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.26 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.42 | |||||
| Debt-to-EBITDA | 2.12 | |||||
| Interest Coverage | 73.57 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.37 | |||||
| Beneish M-Score | -4.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 32.4 | |||||
| 3-Year EBITDA Growth Rate | 32.5 | |||||
| 3-Year EPS without NRI Growth Rate | 30.4 | |||||
| 3-Year Book Growth Rate | 59.1 | |||||
| Future 3-5Y Total Revenue Growth Rate | 14.43 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 83.82 | |||||
| 9-Day RSI | 78.03 | |||||
| 14-Day RSI | 73.75 | |||||
| 6-1 Month Momentum % | 3.96 | |||||
| 12-1 Month Momentum % | -21.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.94 | |||||
| Quick Ratio | 0.86 | |||||
| Cash Ratio | 0.68 | |||||
| Days Inventory | 137.27 | |||||
| Days Sales Outstanding | 107.57 | |||||
| Days Payable | 14.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.91 | |||||
| Dividend Payout Ratio | 0.32 | |||||
| Forward Dividend Yield % | 0.91 | |||||
| 5-Year Yield-on-Cost % | 0.91 | |||||
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | -2.8 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.72 | |||||
| Operating Margin % | 30.16 | |||||
| Net Margin % | 33.29 | |||||
| FCF Margin % | -102.21 | |||||
| ROE % | 14.02 | |||||
| ROA % | 9.44 | |||||
| ROIC % | 10.66 | |||||
| ROC (Joel Greenblatt) % | 25.7 | |||||
| ROCE % | 14.93 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.28 | |||||
| Forward PE Ratio | 14.33 | |||||
| PE Ratio without NRI | 35.51 | |||||
| Price-to-Owner-Earnings | 26.25 | |||||
| PEG Ratio | 1.24 | |||||
| PS Ratio | 8.37 | |||||
| PB Ratio | 3.35 | |||||
| Price-to-Tangible-Book | 3.53 | |||||
| Price-to-Operating-Cash-Flow | 17.98 | |||||
| EV-to-EBIT | 18.83 | |||||
| EV-to-EBITDA | 16.69 | |||||
| EV-to-Revenue | 8.09 | |||||
| EV-to-FCF | -7.92 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.77 | |||||
| Price-to-Graham-Number | 2.36 | |||||
| Earnings Yield (Greenblatt) % | 5.31 | |||||
| FCF Yield % | -12.59 | |||||
| Forward Rate of Return (Yacktman) % | 18.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio Plus Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 53,478.964 | ||
| EPS (TTM) (â‚©) | 305 | ||
| Beta | 1.18 | ||
| Volatility % | 48.34 | ||
| 14-Day RSI | 73.75 | ||
| 14-Day ATR (â‚©) | 433.722472 | ||
| 20-Day SMA (â‚©) | 6511.5 | ||
| 12-1 Month Momentum % | -21.64 | ||
| 52-Week Range (â‚©) | 4250 - 8010 | ||
| Shares Outstanding (Mil) | 56.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio Plus Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio Plus Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bio Plus Co Ltd Frequently Asked Questions
What is Bio Plus Co Ltd(XKRX:099430)'s stock price today?
The current price of XKRX:099430 is â‚©7710.00. The 52 week high of XKRX:099430 is â‚©8010.00 and 52 week low is â‚©4250.00.
When is next earnings date of Bio Plus Co Ltd(XKRX:099430)?
The next earnings date of Bio Plus Co Ltd(XKRX:099430) is .
Does Bio Plus Co Ltd(XKRX:099430) pay dividends? If so, how much?
The Dividend Yield %  of Bio Plus Co Ltd(XKRX:099430) is 0.91% (As of Today), Highest Dividend Payout Ratio of Bio Plus Co Ltd(XKRX:099430) was 0.32. The lowest was 0.17. And the median was 0.18. The  Forward Dividend Yield % of Bio Plus Co Ltd(XKRX:099430) is 0.91%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers